The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
William Chen
No Relationships to Disclose
 
Mikhail Dias
No Relationships to Disclose
 
Chien-Kuang Ding
Research Funding - Bristol Myers Squibb Foundation (Inst); Intuitive Surgical (Inst); Merck (Inst)
 
Stefanie Engler
No Relationships to Disclose
 
Sophie Déglise
No Relationships to Disclose
 
Aishwarya Subramanian
No Relationships to Disclose
 
Haolong Li
No Relationships to Disclose
 
Andrea Jacobs
No Relationships to Disclose
 
Martin Sjöström
Honoraria - Astellas Pharma
Consulting or Advisory Role - Adelphi Targis; Veracyte
Research Funding - PFS Genomics (Inst); PFS Genomics (Inst)
 
Jonathan Chou
Consulting or Advisory Role - Bicycle Therapeutics; Exai Bio; Inversion Therapeutics
Research Funding - Amgen (Inst)
 
Julian Hong
Research Funding - Roche (Inst)
 
Shuang Zhao
Employment - Artera (I)
Stock and Other Ownership Interests - Exact Sciences (I)
Consulting or Advisory Role - Artera
Patents, Royalties, Other Intellectual Property - Patent applications licensed to Veracyte (Inst)
 
Jeff Simko
Stock and Other Ownership Interests - Alpenglow biosciences; Protean Biodiagnostics; Triopsy Medical Inc.
Consulting or Advisory Role - Uro-1
Research Funding - Intuitive Surgical (Inst)
 
Eric Small
Stock and Other Ownership Interests - Fortis; Teon Therapeutics
 
Alan Ashworth
Leadership - Cambridge Science Corporation; CytomX Therapeutics
Stock and Other Ownership Interests - Ambagon Therapeutics; Azkarra Therapeutics; Bluestar Genomics; Circle Pharma; Earli; Gladiator Biosciences; Kytarro; OVIBIO; Phoenix Molecular Designs; ProLynx; Tango Therapeutics; Trial Library; Yingli Pharma
Consulting or Advisory Role - Ambagon Therapeutics; Azkarra Therapeutics; Bluestar Genomics; Circle Pharma; Earli; Genentech; Gladiator Biosciences; GlaxoSmithKline; Kytarro; Novartis; OVIBIO; Phoenix Molecular Designs; Prolynx; Tango Therapeutics; Trial Library; Yingli Pharma
Research Funding - AstraZeneca; SPARC
 
David Quigley
No Relationships to Disclose
 
Peter Carroll
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; Nutcracker Therapeutics, Inc.
Consulting or Advisory Role - Janssen
Research Funding - Artera (Inst); Intuitive Surgical (Inst); Progenics (Inst)
 
Matthew Cooperberg
Consulting or Advisory Role - Alessa Therapeutics; Astellas Pharma; AstraZeneca; Bayer; Dendreon; GlaxoSmithKline; Janssen; LynxDx; Merck; Pfizer; Tempus; Veracyte; Verana Health
 
Bernd Bodenmiller
Leadership - Navignostics
Stock and Other Ownership Interests - Navignostics
Consulting or Advisory Role - Standard BioTools
 
Felix Feng
Employment - University of California at San Francisco; University of California at San Francisco (I)
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics